Secondary Logo

Journal Logo

Considerations in reporting palliative care clinical trials: standardizing information reported and authorship practices Erratum

Current Opinion in Supportive and Palliative Care: March 2013 - Volume 7 - Issue 1 - p 129
doi: 10.1097/SPC.0b013e32835f1e6e
ERRATA
Free

The Conflicts of Interest statement in the article, ‘Considerations in reporting palliative care clinical trials: standardizing information reported and authorship practices,’ which published in the December 2012 issue of the journal, was stated incorrectly [1].

The correct Conflicts of Interest statement should read as follows:

Back to Top | Article Outline

Conflicts of interest

Disclosures/conflicts: This work was supported in part by a grant from the National Institute of Nursing Research (NINR GRANT UC4-NR12584). Dr A.P.A. has research funding from the US National Institutes of Health, US Agency for Healthcare Research and Quality, Robert Wood Johnson Foundation, BioVex, DARA, Helsinn, MiCo and Pfizer; these funds are all distributed to Duke University Medical Center to support research including salary support for A.P.A. In the last 2 years, she has had nominal consulting agreements with or received honoraria from (<US$5000 annually) Novartis and Pfizer. Consulting with Bristol Meyers Squibb is pending in 2012, for role as Co-Chair of a Scientific Advisory Committee.

J.S.K. has research funding from the US National Institutes of Health and US Agency for Healthcare Research and Quality and is a Medical Editor for the Foundation for Informed Medical Decision Making.

The other authors have no disclosures or conflicts to declare.

Back to Top | Article Outline

REFERENCE

1. LeBlanc TW, Abernethy AP, Currow DC, Kutner JS. Considerations in reporting palliative care clinical trials: standardizing information reported and authorship practices. Curr Opin Support Palliat Care 2012; 6:494–499.
© 2013 Lippincott Williams & Wilkins, Inc.